Patents by Inventor Jeanne M. Soos

Jeanne M. Soos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Orally-administered interferon-tau compositions and methods
    Patent number: 7214367
    Abstract: The present invention includes interferon-tau (IFN?) pharmaceutical compositions useful for oral administration to treat cancers, autoimmune disorders (particularly multiple sclerosis), cell proliferative disorders and viral disease.
    Type: Grant
    Filed: October 27, 2003
    Date of Patent: May 8, 2007
    Inventors: Jeanne M. Soos, Joel Schiffenbauer, Howard Marcellus Johnson
  • Orally-administered interferon-tau compositions and methods
    Patent number: 6942854
    Abstract: The present invention includes interferon-tau (IFN?) pharmaceutical compositions useful for oral administration to treat cancers, autoimmune disorders (particularly multiple sclerosis), cell proliferative disorders and viral disease.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: September 13, 2005
    Assignee: University of Florida
    Inventors: Jeanne M. Soos, Joel Schiffenbauer, Howard Marcellus Johnson
  • Orally-administered interferon-tau compositions and methods
    Publication number: 20040086534
    Abstract: The present invention includes interferon-tau (IFN&tgr;) pharmaceutical compositions useful for oral administration to treat cancers, autoimmune disorders (particularly multiple sclerosis), cell proliferative disorders and viral disease.
    Type: Application
    Filed: October 27, 2003
    Publication date: May 6, 2004
    Applicant: University of Florida
    Inventors: Jeanne M. Soos, Joel Schiffenbauer, Howard Marcellus Johnson
  • Orally-administered interferon-tau compositions and methods
    Publication number: 20030012766
    Abstract: The present invention includes interferon-tau (IFNT) pharmaceutical compositions useful for oral administration to treat cancers, autoimmune disorders (particularly multiple sclerosis), cell proliferative disorders and viral disease.
    Type: Application
    Filed: December 21, 2001
    Publication date: January 16, 2003
    Applicant: University of Florida
    Inventors: Jeanne M. Soos, Joel Schiffenbauer, Howard Marcellus Johnson
  • Materials and methods for treating autoimmune disease
    Patent number: 6403562
    Abstract: The subject invention pertains to novel methods for treating autoimmune-related diseases, such as Multiple Sclerosis (MS). One embodiment of the method of the invention comprises administering interleukin-10 (IL-10) and transforming growth factor-beta (TGF-&bgr;), in combination, to a person afflicted with or predisposed to an autoimmune disease. When administered in combination, these cytokines act in a synergistic manner as suppressor factors to inhibit the activation of self-reactive T cells that are involved in autoimmune disease.
    Type: Grant
    Filed: July 27, 1999
    Date of Patent: June 11, 2002
    Assignee: University of Florida
    Inventors: Howard M. Johnson, Mustafa G. Mujtaba, Jeanne M. Soos
  • Orally-administered interferon-TAU compositions and methods
    Patent number: 6372206
    Abstract: The invention includes interferon-tau (IFN&tgr;) pharmaceutical compositions useful for oral administration to treat autoimmune disorders (particularly multiple sclerosis), cell proliferative disorders and viral disease.
    Type: Grant
    Filed: March 15, 1996
    Date of Patent: April 16, 2002
    Assignee: University of Florida
    Inventors: Jeanne M. Soos, Joel Schiffenbauer, Howard Marcellus Johnson
  • Materials and methods for treating autoimmune disease
    Patent number: 6083919
    Abstract: The subject invention pertains to novel methods for treating autoimmune-related diseases, such as Multiple Sclerosis (MS). One embodiment of the method of the invention comprises administering interleukin-10 (IL-10) and transforming growth factor-beta (TGF-.beta.), in combination, to a person afflicted with or predisposed to an autoimmune disease. When administered in combination, these cytokines act in a synergistic manner as suppressor factors to inhibit the activation of self-reactive T cells that are involved in autoimmune disease.
    Type: Grant
    Filed: December 5, 1997
    Date of Patent: July 4, 2000
    Assignee: University of Florida
    Inventors: Howard M. Johnson, Mustafa G. Mujtaba, Jeanne M. Soos
  • Method for treatment of autoimmune diseases
    Patent number: 6060450
    Abstract: Methods of treating autoimmune disorders, such as multiple sclerosis, are disclosed. The methods employ administration of interferon-tau (IFN.tau.) in a therapeutically-effective dose.
    Type: Grant
    Filed: May 25, 1999
    Date of Patent: May 9, 2000
    Assignee: University of Florida
    Inventors: Jeanne M. Soos, Joel Schiffenbauer, Howard Marcellus Johnson
  • Method for treatment of autoimmune diseases
    Patent number: 5906816
    Abstract: Methods of treating autoimmune disorders, such as multiple sclerosis, are disclosed. The methods employ administration of interferon-tau (IFN.tau.) in a therapeutically-effective dose.
    Type: Grant
    Filed: March 16, 1995
    Date of Patent: May 25, 1999
    Assignee: University of Florida
    Inventors: Jeanne M. Soos, Joel Schiffenbauer, Howard Marcellus Johnson